Reference 2018-665

REF:           2018-665

Subject:       Dermatitis treatments and patient numbers

 

Request:

Question 1

How many patients are currently (within the last 3 months) being treated for moderate or severe atopic dermatitis (also known as eczema) ?

Question 1b

Of these treated patients how many are paediatric ?

Question 2

How many patients are currently being treated for moderate or severe atopic dermatitis (also known as eczema) with the following drugs ?

Drug Name Total
Acitretin
Alitretinoin
Pimecrolimus
Tacrolimus
Dupixent (Dupilumab)
Phototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA)
Potent Topical Corticosteroids (creams or ointments) total
Amcinonide 0.05% (Cyclocort)
Betamethasone diproprionate 0.05% (Diprosone)
Betamethasone valerate
Clobetasol proionate
Desoximetasone 0.25% (Topicort)
Diflucortolone valerate
Fluocinonide 0.05% (Lidex)
Fluticasone proprionate 0.005% (Cutivate)
Halcinonide 0.05% (Halog)
Mometasone furoate 0.1% (Elocon ointment)
Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream)
Betamethasone dipropionate 0.25% (Diprolene)
Clobetasol dipropionate 0.05% (Temovate)
Diflorasone diacetate 0.05% (Psorcon)
Halbetasol proprionate 0.05% (Ultravate)
Immunosppressive therapies total
Azathioprine
Ciclosporin
Methotrexate

 

Question 3

Does your Trust use any of the following to treat severe dermatitis ? If so how many patients in the past 3 months ?

Drug Name Total
Etanercept
Infliximab
Adalimumab
Ustekinumab

 

 

Response:

Please find information attached.

2018-665 – FOI Request – Dermatitis treatments and patient numbers [12 kb] MS Excel

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close